Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
BTK

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

BTK

Chemical Structure Cat. No. Product Name CAS No.
QL47 Chemical Structure
 BCP30763 QL47 1469988-75-7
QL47 is a potent, selective and irreversible BTK kinase inhibitor with IC50 of 7 nM.
BMX-IN-1 Chemical Structure
 BCP30306 BMX-IN-1 1431525-23-3
BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related Bruton’s tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.
PCI-29732 Chemical Structure
 BCP30138 PCI-29732 330786-25-9
PCI-29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.
(R)-Zanubrutinib Chemical Structure
 BCP30082 (R)-Zanubrutinib 1691249-44-1
(R)-Zanubrutinib is the R enantiomer of Zanubrutinib. Zanubrutinib is a selective Bruton tyrosine kinase (BTK) inhibitor.
Zanubrutinib Chemical Structure
 BCP29110 Zanubrutinib 1691249-45-2
Zanubrutinib is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.
Vecabrutinib Chemical Structure
 BCP29646 Vecabrutinib 1510829-06-7
Vecabrutinib, also known as SNS-062; FP-182, BSK-4841 and BIIB-062; is a potent, noncovalent, reversible BTK inhibitor that inhibits signaling through the BCR pathway.
BMS-986142 Chemical Structure
 BCP29622 BMS-986142 1643368-58-4
BMS-986142 is a potent and highly selective reversible inhibitor of Bruton's tyrosine kinase (BTK) with an IC50 of 0.5 nM.
BMS-986195 Chemical Structure
 BCP29496 BMS-986195 1912445-55-6
BMS-986195 is a potent, covalent, irreversible inhibitor of Bruton’s tyrosine kinase (BTK), with an IC50 of <1 nM.
ARQ-531 Chemical Structure
 BCP29029 ARQ-531 2095393-15-8
ARQ-531 is a potent and orally active BTK inhibitor with potential antineoplastic activity.
Btk inhibitor 2 Chemical Structure
 BCP25149 Btk inhibitor 2 1558036-85-3
Btk inhibitor 2 is a Bruton's tyrosine kinase (BTK) inhibitor extracted from patent US 20170224688 A1.
123下一页末页共 31 条记录 1 / 4 页 
0086-15971444841